S. Lheureux
Reproductive Medicine · 2019
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Reproductive Medicine — 70 citations into it
- Obstetrics and Gynecology — 8 citations into it
Whom S. Lheureux trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from S. Lheureux's perspective
Ordered by how strongly the researchers S. Lheureux trusts endorse each paper. Same corpus, a different order for every researcher.
- Global cancer statistics (Ca)
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy (Nature)
- Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. (The Lancet)
- Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. (Journal of Clinical Oncology)
- A candidate precursor to serous carcinoma that originates in the distal fallopian tube
- Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. (Journal of Clinical Oncology)
- The Origin and Pathogenesis of Epithelial Ovarian Cancer- a Proposed Unifying Theory (American Journal of Surgical Pathology)
- Nonparametric Estimation from Incomplete Observations
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study. (The Lancet Oncology)
- Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial. (The Lancet Oncology)
Their papers
- Epithelial ovarian cancer. (2019) — 762 citations
- Epithelial ovarian cancer: Evolution of management in the era of precision medicine (2019) — 1,318 citations